Autolus Therapeutics plc

AUTL · Biological Products, (No Disgnostic Substances)

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • AUTL · 05280R100 - ADSs, each representing one ordinary share, nominal value $0.000042 per share, and ordinary shares, nominal value $0.000042 per share
Company details and SEC sources

CIK 0001730463 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
AUTL on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
Business address
The Mediaworks, 191 Wood Lane, London, United Kingdom, W12 7FP
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
United Kingdom
Fiscal year end
31 December
Former names on EDGAR
Autolus Therapeutics Ltd (to 08 Jun 2018)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .